6/24/24 16:29 | 6/20/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 79 | 0.2584 | 0 | 305 | 81 | 680 | D | | | | | | | | | | | | | | |
6/20/24 16:15 | 6/18/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | P | 4 | 0.2477 | 0 | 18 | 33 | 71 | D | | | | | | | | | | | | | | |
9/25/23 16:21 | 9/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 90 | 1.38 | 0 | 65 | 21 | 375 | D | | | | | | | | | | | | | | |
5/11/23 17:08 | 5/10/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 47 | 1.56 | 0 | 30 | 47 | 93 | D | | | | | | | | | | | | | | |
5/9/23 17:00 | 5/8/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Johnson Bruce S | MD | O | SVP,Chie | P | 21 | 1.57 | 0 | 14 | 11 | 139 | D | | | | | | | | | | | | | | |
2/23/23 18:23 | 2/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P.m | 712 | 1.78 | 0 | 400 | 5 | 8,489 | D | | | | | | | | | | | | | | |
2/17/23 17:29 | 2/15/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P.m | 3,028 | 2.00 | 0 | 1,515 | 23 | 8,089 | D | | | | | | | | | | | | | | |
2/13/23 17:45 | 2/9/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P | 37 | 3.24 | 0 | 11 | 0 | 6,574 | D | | | | | | | | | | | | | | |
12/27/22 18:41 | 12/22/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P | 248 | 2.25 | 0 | 110 | 55 | 310 | D | | | | | | | | | | | | | | |
11/18/22 16:01 | 11/17/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 37 | 1.87 | 0 | 20 | 46 | 63 | D | | | | | | | | | | | | | | |
11/16/22 16:26 | 11/14/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 309 | 1.55 | 0 | 200 | New | 200 | D | | | | | | | | | | | | | | |
11/14/22 16:14 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Pearson Timothy R | MD | D | | P | 25 | 1.29 | 0 | 19 | 370 | 25 | D | | | | | | | | | | | | | | |
11/14/22 16:13 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Semerjian Harout | MD | DO | CEO | P | 32 | 1.29 | 0 | 25 | New | 25 | D | | | | | | | | | | | | | | |
11/14/22 16:13 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | P | 21 | 1.06 | 0 | 20 | 54 | 57 | D | | | | | | | | | | | | | | |
11/14/22 16:11 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | O | SVP of R | P | 53 | 1.17 | 0 | 45 | 14 | 371 | D | | | | | | | | | | | | | | |
11/14/22 16:04 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Girard Armand | MD | O | SVP,Chie | P | 7 | 1.05 | 0 | 7 | 29 | 29 | D | | | | | | | | | | | | | | |
11/18/21 16:05 | 11/16/21 | GLYC | Health | Drug | Pharmaceutical Preparations | Andrews Patricia S | MD | D | | P | 82 | 2.05 | 0 | 40 | 762 | 45 | D | | | | | | | | | | | | | | |
11/6/20 18:33 | 11/4/20 | GLYC | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | | P | 3,294 | 2.60 | 0 | 1,267 | | 630 | D | | | | | | | | | | | | | | |
11/3/20 16:44 | 10/30/20 | GLYC | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | | P | 2,565 | 2.75 | 0 | 933 | | 544 | D | | | | | | | | | | | | | | |
3/10/20 18:12 | 3/9/20 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 68 | 3.40 | 0 | 20 | 111 | 38 | D | | | | | | | | | | | | | | |
9/9/19 16:49 | 9/5/19 | GLYC | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | | P | 5,310 | 3.18 | 0 | 1,669 | | 529 | D | | | | | | | | | | | | | | |
8/15/19 16:03 | 8/13/19 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 32 | 3.18 | 0 | 10 | 125 | 18 | D | | | | | | | | | | | | | | |
12/21/16 16:23 | 12/20/16 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 30 | 6.01 | 0 | 5 | New | 5 | D | -30 | -4 | -2 | -18 | 4 | -4 | 3 | 0 | 1 | 1 | -5 | -6 | | |
3/7/16 08:03 | 3/4/16 | GLYC | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MD | D | | P | 50 | 4.77 | 0 | 10 | 945 | 11 | D | -65 | -37 | -26 | -25 | 3 | 32 | 4 | 15 | 18 | 9 | 18 | 73 | 43 | 24 |
6/13/14 16:01 | 6/12/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Henos Michael A | MD | D | | P.m | 70 | 6.39 | 1 | 11 | 2 | 489 | D | | | | -61 | -49 | -1 | -11 | -5 | 7 | 18 | 45 | 26 | 41 | 26 |
1/15/14 17:16 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Barris Peter J | MD | T | | P.d | 8,000 | 8.00 | 13 | 1,000 | 13 | 8,575 | I | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |
1/15/14 17:15 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | P.d | 8,000 | 8.00 | 13 | 1,000 | 13 | 8,575 | I | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |
1/15/14 17:15 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Barrett M James | MD | DT | | P.d | 8,000 | 8.00 | 13 | 1,000 | 13 | 8,575 | I | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |
1/15/14 17:14 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 13 LP | MD | T | | P.d | 4,100 | 8.00 | 13 | 513 | 14 | 4,093 | D | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |
1/15/14 17:13 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 10 L P | MD | T | | P.d | 3,900 | 8.00 | 13 | 488 | 12 | 4,482 | D | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |